Nebkliq (Amlodipine Besilate, Nebivolol Hydrochloride)

Nebkliq is indicated for hypertension, a condition characterized by elevated arterial pressure.

• Essential hypertension: reduces both systolic and diastolic blood pressure.
• Isolated systolic hypertension: lowers high systolic readings while maintaining diastolic stability.
• Diastolic hypertension: contributes to decreasing elevated diastolic pressure.

• Amlodipine besilate blocks L‑type calcium channels in vascular smooth muscle, causing vasodilation and reduced peripheral resistance. Nebivolol hydrochloride selectively antagonizes β1‑adrenergic receptors, decreasing heart rate and contractility, while also stimulating endothelial nitric‑oxide release, further enhancing vasodilation. The combined actions lower cardiac output and systemic vascular resistance, resulting in an overall reduction of arterial blood pressure.

Nebkliq may cause a range of adverse reactions, varying from common to rare.

Common Side Effects

• Headache: mild to moderate intensity.
• Peripheral edema: swelling of ankles or feet.
• Dizziness or light‑headedness, especially after standing.
• Flushing: transient warmth and redness of the skin.
• Fatigue: general feeling of tiredness.
• Palpitations: awareness of heartbeat.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure leading to fainting.
• Bradycardia: abnormally slow heart rate.
• Heart block or atrioventricular conduction disturbances.
• Angioedema: swelling of face, lips, tongue, or throat.
• Significant liver enzyme elevation.
• Allergic reactions: rash, itching, or anaphylaxis.

Before initiating Nebkliq, consider the following precautions.

• Blood pressure monitoring: regularly assess to avoid excessive hypotension.
• Cardiac function evaluation: review history of heart failure or conduction disorders.
• Concomitant beta‑blocker use: avoid additive effects that may cause bradycardia.
• Hepatic impairment: adjust therapy if liver function is compromised.
• Pregnancy and lactation: discuss risks with a healthcare professional before use.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nebkliq can interact with several medicines; categorize them as follows.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase plasma levels.
• Other antihypertensives (e.g., ACE inhibitors, diuretics): risk of additive hypotension.
• Non‑dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem): can cause severe bradycardia.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce efficacy.
• NSAIDs: may blunt antihypertensive effect.
• Antidiabetic agents: monitor blood glucose as blood pressure changes can affect glycemic control.